API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
API
BP/USP
C20H21CLO4
propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
49562-28-9
360.83 g/mol
Phenoxyisobutyric acid derivative
Antilipemic
| Appearance | Off-White Crystalline Solid |
|---|---|
| Solubility | Practically insoluble in water; soluble in methanol, ethanol, and acetone |
| Melting Point | 79–82°C |
| pH | - |
Fenofibrate is a lipid-lowering medication belonging to the fibrate class. It is primarily used to reduce high levels of triglycerides and cholesterol in the blood, helping to prevent cardiovascular disease. As a prodrug, fenofibrate is converted in the body to its active form, fenofibric acid, which activates peroxisome proliferator-activated receptors (PPARα). This activation increases the breakdown of fats and improves lipid metabolism. Fenofibrate is commonly prescribed alongside diet and lifestyle changes to manage hyperlipidemia and hypertriglyceridemia.
Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), a nuclear receptor that regulates gene expression involved in lipid metabolism. Activation of PPARα increases the breakdown of triglyceride-rich lipoproteins, reduces triglyceride levels, and raises HDL (“good”) cholesterol. This helps improve overall lipid profiles and lowers the risk of cardiovascular disease.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO GMP, ISO 9001:2015, FDA audited facilities |
| Affordability & Generic Access | Cost competitive generics for global supply |
| Export Experience | Proven track record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
It’s used to lower high cholesterol and triglycerides and reduce cardiovascular risk.
It activates PPARα receptors to improve lipid metabolism and reduce blood fats.
Usually once daily with food to improve absorption.
Yes, Salius Pharma exports Fenofibrate API to both African and Middle Eastern countries. The company has a strong global presence, including in regions such as Nigeria, Kenya, Ghana, South Africa in Africa, and Saudi Arabia, United Arab Emirates, Oman, Jordan in the Middle East. Salius Pharma offers a wide range of chronic therapy APIs, including Fenofibrate, to these regions, aiming to provide quality, affordable healthcare solutions.
Looking to source Fenofibrate or other high-quality pharmaceutical products?
We’re here to help.
Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support,
our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.